Marshall Wace, LLP
- SEC CIK
- 0001318757
- Latest filing
- Aug 13, 2026
ACAD holding history
Acadia Pharmaceuticals Inc in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ACAD overviewAll 13F holders of ACADFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,764,838
- Value
- $44.7M
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,764,838 | $44.7M | <0.1% | +1,688,651+2,216.5% | Added | Holders |
| Q1 2026 | 76,187 | $1.70M | <0.1% | −417,192−84.6% | Reduced | Holders |
| Q4 2025 | 493,379 | $13.2M | <0.1% | −1,865,502−79.1% | Reduced | Holders |
| Q3 2025 | 2,358,881 | $50.3M | 0.1% | +389,170+19.8% | Added | Holders |
| Q2 2025 | 1,969,711 | $42.5M | 0.1% | +1,639,315+496.2% | Added | Holders |
| Q1 2025 | 330,396 | $5.49M | <0.1% | −663,197−66.7% | Reduced | Holders |
| Q4 2024 | 993,593 | $18.2M | <0.1% | −195,019−16.4% | Reduced | Holders |
| Q3 2024 | 1,188,612 | $18.3M | <0.1% | −1,585,741−57.2% | Reduced | Holders |
| Q2 2024 | 2,774,353 | $45.1M | 0.1% | +2,251,940+431.1% | Added | Holders |
| Q1 2024 | 522,413 | $9.66M | <0.1% | +522,413 | New | Holders |
| Q4 2023 | 0 | $0 | 0.0% | −941,755−100.0% | Sold out | Holders |
| Q3 2023 | 941,755 | $19.6M | <0.1% | +916,903+3,689.5% | Added | Holders |
| Q2 2023 | 24,852 | $595.2K | <0.1% | +24,852 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −532,557−100.0% | Sold out | Holders |
| Q1 2022 | 532,557 | $12.9M | <0.1% | +532,557 | New | Holders |